3 Key Takeaways
Plain English Summary- 01Core Finding
Patients experience muscle damage with fibro-fatty replacement, leading to poor strength recovery, but the pathogenesis remains unclear.
- 02Study Evidence
Tested in a observational cohort study at the real-world cohort stage.
- 03Practical Meaning
Observational cohort findings reveal real-world links, though lifestyle or unmeasured factors cannot be fully ruled out without an RCT.
What This Means for You
These cells carried a strong proportion of IMNM-enriched pathological signatures, notably a complement-linked 'tumour-like' inflammatory fibroblast signature and a specific interferon (an immune-signaling protein) response, characterised by the expression of metallothioneins. Peri-necrotic areas were characterised by pathological muscle signatures carrying interferon response and FABP4+ metabolically dysfunctional signatures. In conclusion, IMNM necrotic muscle areas are linked to a specific SFRP4-expressing fibroblast subtype interacting with macrophages, potentially driving the pathological muscle phenotype and contributing to inflammation, fibro-fatty replacement, and strength loss.
The Discovery
Immune-mediated necrotising myopathies (IMNM) are characterised by muscle fibre necrosis, complement deposits around non-necrotic fibres, and macrophage infiltrates. Patients experience muscle damage with fibro-fatty replacement, leading to poor strength recovery, but the pathogenesis remains unclear. To investigate IMNM pathogenesis, we applied spatial transcriptomics on myositis muscle biopsies and integrated the results with published single-nucleus transcriptomic data. This combined approach enabled analysis of gene expression with spatial localisation in the muscle. Inflammatory, fibrotic, regenerative, and lipid metabolism-related signatures were identified in IMNM, distinct from other myositis, with specific distribution in necrotic and peri-necrotic regions. A unique subtype of immune-driven fibroblasts expressing SFRP4 was enriched in IMNM necrotic areas.
How It Works, Simply
This immunology research focuses on inflammation · Immune response · Genetics. Researchers evaluated it using an observational cohort study at the real-world cohort stage of medical research.
3 Key Takeaways
Clinical Takeaways- 01Core Finding
Patients experience muscle damage with fibro-fatty replacement, leading to poor strength recovery, but the pathogenesis remains unclear.
- 02Study Evidence
Tested in a observational cohort study at the real-world cohort stage.
- 03Practical Meaning
Observational cohort findings reveal real-world links, though lifestyle or unmeasured factors cannot be fully ruled out without an RCT.
Biological Mechanism & Study Design
Study Design & Cohort
Observational cohort study
Observational cohort study · Real-World Cohort
Biological Pathway & Modality
Inflammation · Immune response · Genetics
Intervention: Spatial transcriptomics in immune-mediated necrotising myopathy uncovers a specific
Experimental Findings & Endpoints
Immune-mediated necrotising myopathies (IMNM) are characterised by muscle fibre necrosis, complement deposits around non-necrotic fibres, and macrophage infiltrates.
Patients experience muscle damage with fibro-fatty replacement, leading to poor strength recovery, but the pathogenesis remains unclear. To investigate IMNM pathogenesis, we applied spatial transcriptomics on myositis muscle biopsies and integrated the results with published single-nucleus transcriptomic data.
This combined approach enabled analysis of gene expression with spatial localisation in the muscle. Inflammatory, fibrotic, regenerative, and lipid metabolism-related signatures were identified in IMNM, distinct from other myositis, with specific distribution in necrotic and peri-necrotic regions.
A unique subtype of immune-driven fibroblasts expressing SFRP4 was enriched in IMNM necrotic areas.
Clinical Translation & Practice Context
These cells carried a strong proportion of IMNM-enriched pathological signatures, notably a complement-linked 'tumour-like' inflammatory fibroblast signature and a specific interferon response, characterised by the expression of metallothioneins.
Peri-necrotic areas were characterised by pathological muscle signatures carrying interferon response and FABP4+ metabolically dysfunctional signatures. In conclusion, IMNM necrotic muscle areas are linked to a specific SFRP4-expressing fibroblast subtype interacting with macrophages, potentially driving the pathological muscle phenotype and contributing to inflammation, fibro-fatty replacement, and strength loss.
The Bottom Line · Clinical Pearl
“In conclusion, IMNM necrotic muscle areas are linked to a specific SFRP4-expressing fibroblast subtype interacting with macrophages, potentially driving the pathological muscle phenotype and contributing to inflammation, fibro-fatty replacement, and strength loss.”
Published in Annals of the Rheumatic Diseases · Current Stage: Real-World Cohort
